Q

Quantum BioPharma Ltd
CNSX:QNTM

Watchlist Manager
Quantum BioPharma Ltd
CNSX:QNTM
Watchlist
Price: 14.33 CAD 2.36% Market Closed
Market Cap: 54.7m CAD

Quantum BioPharma Ltd
EPS (Diluted)

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Quantum BioPharma Ltd
EPS (Diluted) Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company EPS (Diluted) CAGR 3Y CAGR 5Y CAGR 10Y
Q
Quantum BioPharma Ltd
CNSX:QNTM
EPS (Diluted)
-$65
CAGR 3-Years
-184%
CAGR 5-Years
-405%
CAGR 10-Years
N/A
Bausch Health Companies Inc
TSX:BHC
EPS (Diluted)
$0
CAGR 3-Years
11%
CAGR 5-Years
N/A
CAGR 10-Years
-5%
Canopy Growth Corp
TSX:WEED
EPS (Diluted)
-CA$1
CAGR 3-Years
40%
CAGR 5-Years
19%
CAGR 10-Years
N/A
Sundial Growers Inc
NASDAQ:SNDL
EPS (Diluted)
CA$0
CAGR 3-Years
32%
CAGR 5-Years
53%
CAGR 10-Years
N/A
Cronos Group Inc
TSX:CRON
EPS (Diluted)
$0
CAGR 3-Years
N/A
CAGR 5-Years
-20%
CAGR 10-Years
N/A
K
Knight Therapeutics Inc
TSX:GUD
EPS (Diluted)
CA$0
CAGR 3-Years
41%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Quantum BioPharma Ltd
Glance View

Market Cap
49.7m CAD
Industry
Pharmaceuticals

Quantum BioPharma Ltd is a CA-based company operating in Pharmaceuticals industry. The company is headquartered in Toronto, Ontario. The company went IPO on 2018-05-29. Quantum BioPharma Ltd. is a Canada-based biopharmaceutical company. The firm is engaged in building a portfolio of assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders and alcohol misuse disorders with drug candidates in different stages of development. Through its wholly owned subsidiary, Lucid Psycheceuticals Inc. (Lucid), it is focused on the research and development of its lead compound, Lucid-MS, which is a patented new chemical entity to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis. Its unbuzzd beverage is a proprietary formulation of vitamins and minerals to help with liver and brain function for the purposes of relieving the effects of alcohol consumption and restoring a normal lifestyle. The company maintains a portfolio of strategic investments through its wholly owned subsidiary, FSD Strategic Investments Inc., which represents loans secured by residential or commercial property.

QNTM Intrinsic Value
Not Available

See Also

What is Quantum BioPharma Ltd's EPS (Diluted)?
EPS (Diluted)
-65.7 USD

Based on the financial report for Dec 31, 2021, Quantum BioPharma Ltd's EPS (Diluted) amounts to -65.7 USD.

What is Quantum BioPharma Ltd's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 5Y
-405%

Over the last year, the EPS (Diluted) growth was 62%. The average annual EPS (Diluted) growth rates for Quantum BioPharma Ltd have been -184% over the past three years , -405% over the past five years .

Back to Top